Biotech Distilled
Substack ↗ Subscribe
Subscribe Substack ↗ About

Home › Therapeutic areas › Immunology

Immunology (53 companies · 22 conditions)

Conditions

Systemic Lupus Erythematosus 14 Rheumatoid Arthritis 13 Systemic Sclerosis 13 Rare Idiopathic Inflammatory Myopathies 9 Rare Chronic Urticaria 7 Sjögren's Syndrome 7 Ulcerative Colitis 7 Crohn's Disease 5 Psoriatic Arthritis 4 ANCA-Associated Vasculitis 3 Rare Dermatomyositis 3 Rare Food Allergy 3 Hereditary Angioedema 3 Rare Axial Spondyloarthritis 2 Graft-versus-Host Disease 2 Rare Graves' Disease 2 IgG4-Related Disease 2 Rare Cow's Milk Allergy 1 Leukocyte Adhesion Deficiency-I 1 Rare Peanut Allergy 1 Primary Humoral Immunodeficiency 1 Rare Transplant Rejection 1 Rare

Companies

Ticker Company Therapeutic areas In Immunology Lead stage Programs
ACET Adicet Bio ImmunologyNeurology+2 Rare 5 Phase 1 8
ADMA Adma Biologics ImmunologyInfectious Disease Rare 2 Approved 4
AGMB Agomab Therapeutics ImmunologyRespiratory Rare 1 Phase 2 4
ALLO Allogene Therapeutics ImmunologyOncology Rare 3 Phase 2 10
ANAB AnaptysBio DermatologyGI/Hepatology+2 Rare 1 Approved 9
RCUS Arcus Biosciences DermatologyImmunology+1 1 Phase 3 6
ARTV Artiva Biotherapeutics DermatologyImmunology+2 Rare 6 Phase 2 14
AUTL Autolus Therapeutics HematologyImmunology+3 Rare 1 Approved 12
BCRX Biocryst Pharmaceuticals DermatologyImmunology+1 Rare 2 Approved 4
CABA Cabaletta Bio DermatologyImmunology+2 Rare 5 Phase 2 8
RNAC Cartesian Therapeutics ImmunologyNeurology+1 Rare 2 Phase 3 4
CLDX Celldex Therapeutics DermatologyImmunology+1 4 Phase 3 7
IPSC Century Therapeutics ImmunologyMetabolic+1 Rare 6 Phase 1 9
CMMB Chemomab Therapeutics GI/HepatologyImmunology+1 Rare 2 Phase 2 4
CLYM Climb Bio HematologyImmunology+1 Rare 2 Phase 2 7
CUE Cue Biopharma ImmunologyOncology 2 Phase 2 6
CGEM Cullinan Therapeutics HematologyImmunology+2 Rare 4 NDA Submitted 10
DBVT DBV Technologies Immunology 2 NDA Submitted 2
ELDN Eledon Pharmaceuticals ImmunologyMetabolic+1 Rare 1 Phase 2 3
ENTA Enanta Pharmaceuticals DermatologyImmunology+1 1 Approved 7
EVMN Evommune DermatologyImmunology+1 2 Phase 2 5
FATE Fate Therapeutics ImmunologyOncology+1 Rare 4 Phase 2 10
IMVT Immunovant ImmunologyNeurology Rare 3 Phase 3 5
INAB IN8bio ImmunologyOncology 1 Phase 2 6
INSM Insmed CardiovascularImmunology+2 Rare 1 Approved 15
NTLA Intellia Therapeutics CardiovascularImmunology Rare 1 NDA Submitted 3
IONS Ionis Pharmaceuticals CardiovascularHematology+5 Rare 1 Approved 29
JBIO Jade Biosciences ImmunologyRenal Rare 2 Phase 2 4
KYTX Kyverna Therapeutics ImmunologyNeurology+1 Rare 1 NDA Submitted 7
LQDA Liquidia CardiovascularImmunology+1 Rare 1 Approved 10
MGTX MeiraGTx ImmunologyMetabolic+2 Rare 1 Phase 3 16
INKT MiNK Therapeutics ImmunologyOncology+1 Rare 1 Phase 2 8
GLUE Monte Rosa Therapeutics CardiovascularDermatology+3 Rare 1 Phase 2 7
MLTX MoonLake Immunotherapeutics DermatologyImmunology Rare 2 Phase 3 4
NKTR Nektar Therapeutics DermatologyImmunology+2 1 Phase 3 11
NKTX Nkarta ImmunologyNeurology+1 Rare 5 Phase 1 8
NRIX Nurix Therapeutics ImmunologyNeurology+1 1 Phase 3 16
ORKA Oruka Therapeutics DermatologyImmunology Rare 1 Phase 2 7
PTN Palatin Technologies ImmunologyMetabolic+1 Rare 1 Phase 3 8
PALI Palisade Bio Immunology 2 Phase 2 3
PCSA Processa Pharmaceuticals GI/HepatologyImmunology+2 Rare 2 Phase 2 7
PTGX Protagonist Therapeutics DermatologyHematology+2 Rare 3 Approved 14
QNRX Quoin Pharmaceuticals DermatologyImmunology Rare 1 Phase 2 4
RCKT Rocket Pharmaceuticals CardiovascularImmunology Rare 1 Approved 4
SYRE Spyre Therapeutics DermatologyImmunology Rare 11 Phase 2 12
SNDX Syndax Pharmaceuticals ImmunologyOncology+1 Rare 1 Approved 8
TLSA Tiziana Life Sciences ImmunologyNeurology Rare 1 Phase 2 5
VNDA Vanda Pharmaceuticals CardiovascularDermatology+6 Rare 1 Approved 27
VRDN Viridian Therapeutics ImmunologyOphthalmology 1 Approved 5
VOR Vor Biopharma ImmunologyNeurology Rare 1 Phase 3 2
XNCR Xencor ImmunologyNeurology+1 Rare 10 Approved 28
ZBIO Zenas BioPharma DermatologyImmunology+2 Rare 3 NDA Submitted 11
ZURA Zura Bio DermatologyImmunology Rare 1 Phase 2 5